Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,536 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,903 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01742403 | Continuous Monitoring of Prostate Position During Radiotherapy(KIM Gating) | active not recruiting | N/A | 100 | Royal North Shore HospitalOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT04704505 | Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)(BAT-RAD) | recruiting | Phase 2 | 47 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER |
| 2 |
| Feb 6, 2026 |
| clinicaltrials |
| NCT07391982 | Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions(DESTINATION 2) | recruiting | N/A | 54 | The Netherlands Cancer InstituteOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT03260023 | Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers | active not recruiting | Phase 1 / Phase 2 | 143 | TransgeneINDUSTRY | 3 | Feb 5, 2026 | clinicaltrials |
| NCT03902951 | Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer | active not recruiting | Phase 2 | 28 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT04455750 | A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy(CASPAR) | active not recruiting | Phase 3 | 61 | Alliance for Clinical Trials in OncologyOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT04459273 | Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers(FAPI PET RDRC) | active not recruiting | Phase 1 | 26 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT06547398 | Prostate Adaptive Radiation Therapy | recruiting | N/A | 130 | Royal North Shore HospitalOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT06591819 | Hypofractionated WPPT With HDR Boost | recruiting | Phase 2 | 30 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT06631521 | Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer | recruiting | Phase 1 | 30 | AdventHealthOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07001241 | Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors | recruiting | Phase 2 | 134 | University of Colorado, DenverOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07276438 | Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial | recruiting | N/A | 186 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07325721 | Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer | recruiting | Phase 2 | 46 | Medical University of South CarolinaOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07389512 | Pharmaceutical Management in Targeted Radioligand Therapy(PharmTRT) | recruiting | — | 600 | Hospices Civils de LyonOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT02099734 | Germ Cell Tumor and Testicular Tumor DNA Registry | recruiting | — | 1,000 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT04729114 | A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer | recruiting | Phase 1 | 174 | Astellas Pharma Global Development, Inc.INDUSTRY | 2 | Feb 4, 2026 | clinicaltrials |
| NCT05810467 | The Active Surveillance Study(AS) | recruiting | — | 200 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06408298 | HCQ in Resectable Localized Prostate Cancer | recruiting | Early Phase 1 | 20 | Lionel.D.Lewis, MDOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06563388 | Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial(ID-COMET) | recruiting | Phase 3 | 800 | Roswell Park Cancer InstituteOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06636526 | The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study). | recruiting | — | 1,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07335224 | Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture(MPOWER) | recruiting | N/A | 24 | Inova Health Care ServicesOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07386171 | Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance(MUS-AS) | not yet recruiting | N/A | 90 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07386496 | The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI | not yet recruiting | N/A | 250 | Chinese University of Hong KongOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07209176 | Physician- and Patient-based Barriers to NGS Testing | recruiting | N/A | 256 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT04964271 | Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants | active not recruiting | — | 60 | Tethis S.p.A.INDUSTRY | 1 | Feb 2, 2026 | clinicaltrials |
| NCT06200974 | Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer(BrachyTRACKS) | recruiting | — | 100 | British Columbia Cancer AgencyOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT06705803 | Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE) | recruiting | — | 3,000 | University of ChicagoOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT06941363 | Salvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence(SUPERB) | recruiting | — | 50 | University of Milano BicoccaOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07344363 | Prostate Cancer REsearch Using Cross-validation of Innovative Sampling, Integrating LC-MS/MS for Optimized Therapeutic Drug moNitoring(PRECISION) | recruiting | — | 100 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07381582 | Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(161Tb-LNC1011) | not yet recruiting | Early Phase 1 | 15 | Peking Union Medical College HospitalOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT03615599 | Plant-based Diets and Risk of Cancer in the Adventist Health Study-2(AHS-2) | active not recruiting | — | 96,000 | Loma Linda UniversityOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT06700057 | Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.(DOSIPROSTATE) | recruiting | — | 50 | Institut BergoniéOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT07243834 | Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise(ADHERE) | recruiting | N/A | 160 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT01936883 | Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy(BrachyQOL) | active not recruiting | N/A | 195 | British Columbia Cancer AgencyOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT02312401 | Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy | active not recruiting | Phase 2 | 120 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT03322891 | Improving Health Literacy in African-American Prostate Cancer Patients | recruiting | N/A | 210 | Emory UniversityOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT03386045 | Optimal Prostate Study | active not recruiting | N/A | 503 | Royal North Shore HospitalOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT03426748 | LDR vs. HDR Brachytherapy for Prostate Cancer(LDR/HDRmono) | active not recruiting | N/A | 140 | British Columbia Cancer AgencyOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT05806515 | Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | recruiting | Phase 2 | 44 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 29, 2026 | clinicaltrials |
| NCT05864196 | Two Fraction Prostate SBRT With DIL SIB | recruiting | Phase 1 | 80 | NYU Langone HealthOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT06099093 | Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan | recruiting | Phase 4 | 30 | Brigham and Women's HospitalOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT06842264 | The Development and Validation of MRI-AI-based Predictive Models for csPCa | recruiting | — | 3,000 | Peking University First HospitalOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07376057 | Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer | not yet recruiting | — | 150 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT04734730 | Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer | recruiting | Phase 2 | 70 | City of Hope Medical CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT06051942 | PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs | active not recruiting | N/A | 125 | PROCEPT BioRoboticsINDUSTRY | 4 | Jan 28, 2026 | clinicaltrials |
| NCT06371768 | Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors(AYA STEPS) | recruiting | N/A | 260 | Duke UniversityOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT06397703 | ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer | recruiting | Phase 2 | 392 | NYU Langone HealthOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT07210086 | Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R) | recruiting | Phase 2 | 50 | City of Hope Medical CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT07352748 | Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa(MOSAIC) | active not recruiting | — | 30 | Universita di VeronaOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT05968144 | Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness(ADRIAN) | active not recruiting | Phase 1 / Phase 2 | 30 | University of Maryland, BaltimoreOTHER | 1 | Jan 27, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Feb 6, 2026source: clinicaltrials